DAKAR: A parliamentary committee in Gambia said on Tuesday that India-based drug maker Maiden Phar­maceuticals was responsible for the deaths of at least 70 children from acute kidney injury and called on the government to pursue legal action.

The World Health Organisation said in October four medicinal syrups made by Maiden and imported by a local wholesaler were likely linked to the deaths, which have shocked the West African country since July. The drugs were pulled from the shelves and Maiden’s production licence in India was suspended.

According to the WHO, lab analysis confirmed “unacceptable” amounts of diethylene glycol and ethylene glycol in the medicines made by Maiden.

After its investigation, Gambia’s select committee on health reached a similar conclusion. “All the cases of AKI are linked to the consumption of contaminated medical products...manufactured by Maiden Pharm­aceuticals,” the committee’s chairperson Amadou Camara said in a statement to parliament.

Published in Dawn, December 21st, 2022

Opinion

Editorial

On press freedoms
Updated 03 May, 2026

On press freedoms

THE citizenry forgets, to its own peril, how important a free and independent media is in the preservation of their...
Inflation strain
03 May, 2026

Inflation strain

PAKISTAN’S return to double-digit inflation after 21 months signals renewed economic strain where external shocks...
Troubled waters
03 May, 2026

Troubled waters

PAKISTAN’S water crisis is often framed in terms of scarcity. Increasingly, it is also a crisis of contamination....
Iran stalemate
Updated 02 May, 2026

Iran stalemate

THE US and Iran are currently somewhere between war and peace. While a tenuous ceasefire — extended largely due to...
Tax shortfall
02 May, 2026

Tax shortfall

THE Rs684bn shortfall in tax collection during the first 10 months of the fiscal year is a continuation of a...
Teaching inclusion
02 May, 2026

Teaching inclusion

DISCRIMINATORY and exclusionary content in Punjab’s textbooks has been flagged in Inclusive Education for a United...